Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pediatric Cancers × Other neoplasm × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 29 Neoplasms, Plasma Cell 10 Multiple Myeloma 10 Lymphoma 10 Leukemia 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Monoclonal Gammopathy of Undetermined Significance 8 Lymphoma, T-Cell, Cutaneous 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Large-Cell, Anaplastic 8 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Follicular 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Immunoglobulin Light-chain Amyloidosis 8 Immunoblastic Lymphadenopathy 8 Hodgkin Disease 8 Waldenstrom Macroglobulinemia 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Myeloproliferative Disorders 7 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Prolymphocytic 7 Leukemia, Large Granular Lymphocytic 7 Leukemia, Hairy Cell 7 Burkitt Lymphoma 7 Thrombocythemia, Essential 6 Sezary Syndrome 6 Primary Myelofibrosis 6 Myelodysplastic Syndromes 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00575926 2007-12-18

Lingzhi for Cancer Children

Chinese University of Hong Kong

Phase 3 Completed

Pediatric Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡